查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1855916

2025年全球哺乳動物細胞庫市場報告

Mammalian Cell Banking Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，哺乳動物細胞庫市場發展迅速，預計從2024年的28.2億美元成長到2025年的31.4億美元，複合年成長率達11.5%。這一成長與單株抗體需求增加、生物製藥研發投資增加、GMP合規監管要求提高、哺乳動物表現系統應用日益廣泛以及生物製藥核准增加等因素相關。

預計未來幾年哺乳動物細胞庫市場規模將快速成長，到2029年將達到47.9億美元，複合年成長率（CAGR）為11.1%。預測期內的成長主要受以下因素驅動：細胞和基因療法需求的成長、個人化醫療的興起、生物製造基礎設施投資的增加、生物相似藥和生技改良藥研發的拓展，以及應對疫情和疫苗生產的加強。預測期內的關鍵趨勢包括：自動化和數位化追蹤技術的整合、細胞培養技術的進步、再生醫學的進展、無血清和無蛋白培養基的開發，以及冷凍保存和分析技術的改進。

對細胞療法日益成長的需求預計將顯著推動哺乳動物細胞庫市場的擴張。細胞療法是指利用活細胞（通常經過改造或基因工程處理）修復、替換或再生受損組織和器官的先進治療方法，為多種疾病提供標靶解決方案。隨著慢性病和罕見疾病的日益普遍，對更有效、更精準的治療方法的需求也日益成長。哺乳動物細胞庫在支持這些療法方面發揮著至關重要的作用，它提供穩定、高品質的細胞來源，並確保再生療法開發和生產的安全性、擴充性和可靠性。例如，美國基因與細胞治療學會於2024年4月報告稱，處於臨床研發管線中的治療方法數量正在增加，其中I期臨床試驗自2022年下半年以來成長最為強勁，達到11%。對細胞療法需求的激增正在推動哺乳動物細胞庫市場的成長。

慢性病發病率的上升正在推動哺乳動物細胞庫市場的成長。慢性病是指需要持續管理而非治癒的長期疾病，其盛行率正在上升，尤其是在全球人口老化的情況下。老年人更容易患上需要持續照護的慢性病。哺乳動物細胞庫透過提供穩定的高品質細胞來源，有助於開發穩定可靠的細胞治療方法和生技藥品，從而輔助治療這些疾病。例如，國際糖尿病聯盟在2025年4月報告稱，2024年全球約有5.89億20至79歲的成年人患有糖尿病，預計到2050年這一數字將增至8.53億。隨著慢性病盛行率的持續上升，哺乳動物細胞庫服務的需求也隨之成長。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅，以及新冠疫情及其復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球哺乳動物細胞庫：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 終端用戶產業分析
  • 全球哺乳動物細胞庫市場：成長率分析
  • 全球哺乳動物細胞庫市場表現：規模與成長，2019-2024年
  • 全球哺乳動物細胞庫市場預測：規模與成長，2024-2029年，2034年
  • 全球哺乳動物細胞庫：潛在市場規模 (TAM)

第6章 市場細分

  • 全球哺乳動物細胞庫市場依產品類型、表現及預測分類，2019-2024年、2024-2029年、2034年
  • 主細胞庫
  • 工作細胞庫
  • 全球哺乳動物細胞庫市場（依細胞類型分類）：表現及預測，2019-2024年、2024-2029年、2034年
  • 中國倉鼠卵巢哺乳動物細胞庫（CHO）
  • 倉鼠腎臟（BHK）
  • 非秘書（NS0）
  • YB2/0 和 P2/0
  • 人類胚胎腎細胞293（HEK293）及其衍生物
  • 亨麗埃塔·拉克斯（HELA）
  • 全球哺乳動物細胞庫市場依儲存類型、效能和預測分類，2019-2024年、2024-2029年、2034年
  • 液態氮
  • 控速冷凍機
  • 快速冷凍
  • 全球哺乳動物細胞庫市場：依應用、效能和預測分類，2019-2024年、2024-2029年、2034年
  • 藥物研發
  • 疫苗生產
  • 基因治療
  • 單株抗體生產
  • 全球哺乳動物細胞庫市場依最終使用者、效能和預測分類，2019-2024年、2024-2029年、2034年
  • 學術和研究機構
  • 生物製藥公司
  • 受託研究機構（CRO）
  • 全球哺乳動物細胞庫市場：按類型、表現和預測細分主細胞庫（2019-2024年、2024-2029年、2034年）
  • 重組細胞系
  • 融合瘤細胞株
  • 原代細胞系
  • 基因工程細胞系
  • 病毒載體生產細胞株
  • 全球哺乳動物細胞庫市場：依工作細胞庫、類型、表現及預測細分，2019-2024年、2024-2029年、2034年
  • 符合現行良好生產規範 (cGMP) 的細胞庫
  • 研究細胞庫
  • 用於臨床試驗的細胞庫
  • 商業細胞庫
  • 細胞庫穩定性測試

第7章 區域和國家分析

  • 全球哺乳動物細胞庫市場：依地區、績效及預測分類，2019-2024年、2024-2029年、2034年
  • 全球哺乳動物細胞庫市場：依國家、績效及預測分類，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 哺乳動物細胞庫市場：競爭格局
  • 哺乳動物細胞庫市場：公司概況
    • Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Lonza Group AG Overview, Products and Services, Strategy and Financial Analysis
    • Eurofins Scientific SE Overview, Products and Services, Strategy and Financial Analysis
    • Charles River Laboratories International Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • Catalent Inc.
  • Sartorius Stedim Biotech SA
  • Samsung Biologics Co. Ltd.
  • CMIC Holdings Co. Ltd.
  • WuXi Biologics Inc.
  • Fujifilm Diosynth Biotechnologies Inc.
  • Evotec SE
  • AGC Biologics Inc.
  • CordenPharma International GmbH
  • GenScript ProBio Co. Ltd.
  • Syngene International Limited
  • KBI Biopharma Inc.
  • Rentschler Biopharma SE
  • BioVectra Inc.
  • Polpharma Biologics SA

第32章 全球市場競爭基準化分析與儀錶板

第33章 重大併購

第34章 近期市場趨勢

第35章：高潛力市場國家、細分市場與策略

  • 2029年哺乳動物細胞庫市場：提供新機會的國家
  • 2029年哺乳動物細胞庫市場：新興細分市場機會
  • 2029年哺乳動物細胞庫市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章附錄

簡介目錄
Product Code: r38568

Mammalian cell banking is the organized procedure of producing, preserving, and storing well-characterized mammalian cell stocks under strict conditions, typically at very low temperatures, to ensure their long-term survival, genetic consistency, and functional performance. This method maintains the cells' uniformity, prevents contamination, and preserves their original traits over time, providing a reliable and standardized resource for future use.

The primary types of products in mammalian cell banking are master cell bank and working cell bank. A master cell bank (MCB) is a carefully prepared and extensively characterized collection of cells stored in multiple vials under controlled cryogenic conditions. It includes various cell types such as Chinese hamster ovary (CHO), baby hamster kidney (BHK), non-secreting 0 (NS0), YB2/0 and P2/0, human embryonic kidney 293 (HEK293) and derivatives, and HeLa cells. Storage methods include liquid nitrogen, controlled-rate freezing, and flash freezing. Master cell banks are used in drug development, vaccine production, gene therapy, and monoclonal antibody production, serving end users such as academic and research laboratories, biopharmaceutical companies, and contract research organizations (CROs).

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The mammalian cell banking market research report is one of a series of new reports from The Business Research Company that provides mammalian cell banking market statistics, including mammalian cell banking industry global market size, regional shares, competitors with a mammalian cell banking market share, detailed mammalian cell banking market segments, market trends and opportunities, and any further data you may need to thrive in the mammalian cell banking industry. This mammalian cell banking market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The mammalian cell banking market size has grown rapidly in recent years. It will grow from $2.82 billion in 2024 to $3.14 billion in 2025 at a compound annual growth rate (CAGR) of 11.5%. The growth observed during the historic period can be linked to increasing demand for monoclonal antibodies, higher investment in biopharmaceutical research and development, expansion of regulatory requirements for GMP compliance, greater use of mammalian expression systems, and a rise in approvals of biologic drugs.

The mammalian cell banking market size is expected to see rapid growth in the next few years. It will grow to $4.79 billion in 2029 at a compound annual growth rate (CAGR) of 11.1%. The growth projected for the forecast period can be attributed to increasing demand for cell and gene therapies, wider adoption of personalized medicine, rising investment in biomanufacturing infrastructure, expansion of biosimilar and biobetter development, and strengthened pandemic preparedness and vaccine production. Key trends during the forecast period include the integration of automation and digital tracking, advancements in cell culture technologies, progress in regenerative medicine, development of serum-free and protein-free media, and improvements in cryopreservation and analytical techniques.

The growing demand for cell-based therapies is expected to significantly drive the expansion of the mammalian cell banking market. Cell-based therapies involve advanced treatments using living, often modified or engineered, cells to repair, replace, or regenerate damaged tissues and organs, offering targeted solutions for various diseases. As chronic and rare diseases become more prevalent, there is an increasing need for more effective and precise treatments. Mammalian cell banking plays a key role in supporting these therapies by providing a consistent, high-quality cell source, ensuring safety, scalability, and reliability in the development and production of regenerative treatments. For example, the American Society of Gene and Cell Therapy reported in April 2024 that the number of therapies in clinical pipelines has grown, with Phase I trials showing the strongest growth of 11% since late 2022. This surge in demand for cell-based therapies is therefore fueling the growth of the mammalian cell banking market.

The rise in chronic diseases is driving the growth of the mammalian cell banking market. Chronic diseases are long-term conditions that require ongoing management instead of a cure, and their prevalence is increasing, particularly as the global population ages. Older individuals are more prone to developing chronic conditions that demand continuous care. Mammalian cell banking aids in treating these conditions by supplying high-quality, stable cells for the creation of consistent, reliable cell-based therapies and biologics. For instance, the International Diabetes Federation reported in April 2025 that around 589 million adults aged 20 to 79 were living with diabetes in 2024, and this figure is projected to rise to 853 million by 2050. As the incidence of chronic diseases continues to grow, the demand for mammalian cell banking services is also increasing.

Companies in the mammalian cell banking market are advancing the field by developing innovative stable cell line systems that improve cell line productivity, ensure long-term genetic stability, and streamline biopharmaceutical manufacturing. Stable cell line systems are engineered mammalian cells that can consistently produce specific proteins or therapeutic molecules across generations with high genetic stability. For example, WuXi Biologics, a biopharmaceutical company based in China, introduced the WuXia293 Stable platform in August 2024. This HEK293-based stable cell line system is designed for the development and production of challenging biologic molecules. By using proprietary cell line development technology, the platform ensures stable expression, consistent quality, and scalable production, overcoming challenges typically seen with traditional CHO cell systems, such as low yields and compromised quality. The WuXia293 Stable platform provides higher protein yields, better human-like glycosylation, and more efficient production for clinical and commercial use.

Major players in the mammalian cell banking market are Merck KGaA, Thermo Fisher Scientific Inc., Lonza Group AG, Eurofins Scientific SE, Charles River Laboratories International Inc., Catalent Inc., Sartorius Stedim Biotech S.A., Samsung Biologics Co. Ltd., CMIC Holdings Co. Ltd., WuXi Biologics Inc., Fujifilm Diosynth Biotechnologies Inc., Evotec SE, AGC Biologics Inc., CordenPharma International GmbH, GenScript ProBio Co. Ltd., Syngene International Limited, KBI Biopharma Inc., Rentschler Biopharma SE, BioVectra Inc., Polpharma Biologics S.A., and Abzena plc.

North America was the largest region in the mammalian cell banking market in 2024. The regions covered in mammalian cell banking report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the mammalian cell banking market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The mammalian cell banking market consists of sales of cryopreservation media, cell culture reagents, storage vials, cryogenic storage equipment, and quality control kits. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Mammalian Cell Banking Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on mammalian cell banking market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for mammalian cell banking ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The mammalian cell banking market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product Type: Master Cell Bank; Working Cell Bank
  • 2) By Cell Type: Chinese Hamster Ovary Mammalian Cell Banking (CHO); Baby Hamster Kidney (BHK); Non-Secreting 0 (NS0); YB2/0 And P2/0; Human Embryonic Kidney 293 (HEK293) And Derivatives; Henrietta Lacks (HELA)
  • 3) By Storage Type: Liquid Nitrogen; Controlled Rate Freezer; Flash Freezing
  • 4) By Application: Drug Development; Vaccine Production; Gene Therapy; Monoclonal Antibody Production
  • 5) By End User: Academic And Research Laboratories; Biopharmaceutical Companies; Contract Research Organizations (CROs)
  • Subsegments:
  • 1) By Master Cell Bank: Recombinant Cell Lines; Hybridoma Cell Lines; Primary Cell Lines; Genetically Engineered Cell Lines; Viral Vector Producing Cell Lines
  • 2) By Working Cell Bank: Current Good Manufacturing Practice (CGMP)-Compliant Cell Banks; Research-Grade Cell Banks; Clinical Trial Cell Banks; Commercial Production Cell Banks; Stability Testing Cell Banks
  • Companies Mentioned: Merck KGaA; Thermo Fisher Scientific Inc.; Lonza Group AG; Eurofins Scientific SE; Charles River Laboratories International Inc.; Catalent Inc.; Sartorius Stedim Biotech S.A.; Samsung Biologics Co. Ltd.; CMIC Holdings Co. Ltd.; WuXi Biologics Inc.; Fujifilm Diosynth Biotechnologies Inc.; Evotec SE; AGC Biologics Inc.; CordenPharma International GmbH; GenScript ProBio Co. Ltd.; Syngene International Limited; KBI Biopharma Inc.; Rentschler Biopharma SE; BioVectra Inc.; Polpharma Biologics S.A.; Abzena plc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Mammalian Cell Banking Market Characteristics

3. Mammalian Cell Banking Market Trends And Strategies

4. Mammalian Cell Banking Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Mammalian Cell Banking Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Mammalian Cell Banking PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Mammalian Cell Banking Market Growth Rate Analysis
  • 5.4. Global Mammalian Cell Banking Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Mammalian Cell Banking Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Mammalian Cell Banking Total Addressable Market (TAM)

6. Mammalian Cell Banking Market Segmentation

  • 6.1. Global Mammalian Cell Banking Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Master Cell Bank
  • Working Cell Bank
  • 6.2. Global Mammalian Cell Banking Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Chinese Hamster Ovary Mammalian Cell Banking (CHO)
  • Baby Hamster Kidney (BHK)
  • Non-Secreting (NS0)
  • YB2/0 And P2/0
  • Human Embryonic Kidney 293 (HEK293) And Derivatives
  • Henrietta Lacks (HELA)
  • 6.3. Global Mammalian Cell Banking Market, Segmentation By Storage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Liquid Nitrogen
  • Controlled Rate Freezer
  • Flash Freezing
  • 6.4. Global Mammalian Cell Banking Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Drug Development
  • Vaccine Production
  • Gene Therapy
  • Monoclonal Antibody Production
  • 6.5. Global Mammalian Cell Banking Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Academic And Research Laboratories
  • Biopharmaceutical Companies
  • Contract Research Organizations (CROs)
  • 6.6. Global Mammalian Cell Banking Market, Sub-Segmentation Of Master Cell Bank, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Recombinant Cell Lines
  • Hybridoma Cell Lines
  • Primary Cell Lines
  • Genetically Engineered Cell Lines
  • Viral Vector Producing Cell Lines
  • 6.7. Global Mammalian Cell Banking Market, Sub-Segmentation Of Working Cell Bank, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Current Good Manufacturing Practice (cGMP)-Compliant Cell Banks
  • Research-Grade Cell Banks
  • Clinical Trial Cell Banks
  • Commercial Production Cell Banks
  • Stability Testing Cell Banks

7. Mammalian Cell Banking Market Regional And Country Analysis

  • 7.1. Global Mammalian Cell Banking Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Mammalian Cell Banking Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Mammalian Cell Banking Market

  • 8.1. Asia-Pacific Mammalian Cell Banking Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Mammalian Cell Banking Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Mammalian Cell Banking Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Mammalian Cell Banking Market, Segmentation By Storage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Mammalian Cell Banking Market

  • 9.1. China Mammalian Cell Banking Market Overview
  • 9.2. China Mammalian Cell Banking Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Mammalian Cell Banking Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Mammalian Cell Banking Market, Segmentation By Storage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Mammalian Cell Banking Market

  • 10.1. India Mammalian Cell Banking Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Mammalian Cell Banking Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Mammalian Cell Banking Market, Segmentation By Storage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Mammalian Cell Banking Market

  • 11.1. Japan Mammalian Cell Banking Market Overview
  • 11.2. Japan Mammalian Cell Banking Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Mammalian Cell Banking Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Mammalian Cell Banking Market, Segmentation By Storage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Mammalian Cell Banking Market

  • 12.1. Australia Mammalian Cell Banking Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Mammalian Cell Banking Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Mammalian Cell Banking Market, Segmentation By Storage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Mammalian Cell Banking Market

  • 13.1. Indonesia Mammalian Cell Banking Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Mammalian Cell Banking Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Mammalian Cell Banking Market, Segmentation By Storage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Mammalian Cell Banking Market

  • 14.1. South Korea Mammalian Cell Banking Market Overview
  • 14.2. South Korea Mammalian Cell Banking Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Mammalian Cell Banking Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Mammalian Cell Banking Market, Segmentation By Storage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Mammalian Cell Banking Market

  • 15.1. Western Europe Mammalian Cell Banking Market Overview
  • 15.2. Western Europe Mammalian Cell Banking Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Mammalian Cell Banking Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Mammalian Cell Banking Market, Segmentation By Storage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Mammalian Cell Banking Market

  • 16.1. UK Mammalian Cell Banking Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Mammalian Cell Banking Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Mammalian Cell Banking Market, Segmentation By Storage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Mammalian Cell Banking Market

  • 17.1. Germany Mammalian Cell Banking Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Mammalian Cell Banking Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Mammalian Cell Banking Market, Segmentation By Storage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Mammalian Cell Banking Market

  • 18.1. France Mammalian Cell Banking Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Mammalian Cell Banking Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Mammalian Cell Banking Market, Segmentation By Storage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Mammalian Cell Banking Market

  • 19.1. Italy Mammalian Cell Banking Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Mammalian Cell Banking Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Mammalian Cell Banking Market, Segmentation By Storage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Mammalian Cell Banking Market

  • 20.1. Spain Mammalian Cell Banking Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Mammalian Cell Banking Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Mammalian Cell Banking Market, Segmentation By Storage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Mammalian Cell Banking Market

  • 21.1. Eastern Europe Mammalian Cell Banking Market Overview
  • 21.2. Eastern Europe Mammalian Cell Banking Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Mammalian Cell Banking Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Mammalian Cell Banking Market, Segmentation By Storage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Mammalian Cell Banking Market

  • 22.1. Russia Mammalian Cell Banking Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Mammalian Cell Banking Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Mammalian Cell Banking Market, Segmentation By Storage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Mammalian Cell Banking Market

  • 23.1. North America Mammalian Cell Banking Market Overview
  • 23.2. North America Mammalian Cell Banking Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Mammalian Cell Banking Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Mammalian Cell Banking Market, Segmentation By Storage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Mammalian Cell Banking Market

  • 24.1. USA Mammalian Cell Banking Market Overview
  • 24.2. USA Mammalian Cell Banking Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Mammalian Cell Banking Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Mammalian Cell Banking Market, Segmentation By Storage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Mammalian Cell Banking Market

  • 25.1. Canada Mammalian Cell Banking Market Overview
  • 25.2. Canada Mammalian Cell Banking Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Mammalian Cell Banking Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Mammalian Cell Banking Market, Segmentation By Storage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Mammalian Cell Banking Market

  • 26.1. South America Mammalian Cell Banking Market Overview
  • 26.2. South America Mammalian Cell Banking Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Mammalian Cell Banking Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Mammalian Cell Banking Market, Segmentation By Storage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Mammalian Cell Banking Market

  • 27.1. Brazil Mammalian Cell Banking Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Mammalian Cell Banking Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Mammalian Cell Banking Market, Segmentation By Storage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Mammalian Cell Banking Market

  • 28.1. Middle East Mammalian Cell Banking Market Overview
  • 28.2. Middle East Mammalian Cell Banking Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Mammalian Cell Banking Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Mammalian Cell Banking Market, Segmentation By Storage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Mammalian Cell Banking Market

  • 29.1. Africa Mammalian Cell Banking Market Overview
  • 29.2. Africa Mammalian Cell Banking Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Mammalian Cell Banking Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Mammalian Cell Banking Market, Segmentation By Storage Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Mammalian Cell Banking Market Competitive Landscape And Company Profiles

  • 30.1. Mammalian Cell Banking Market Competitive Landscape
  • 30.2. Mammalian Cell Banking Market Company Profiles
    • 30.2.1. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Lonza Group AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Eurofins Scientific SE Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Charles River Laboratories International Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Mammalian Cell Banking Market Other Major And Innovative Companies

  • 31.1. Catalent Inc.
  • 31.2. Sartorius Stedim Biotech S.A.
  • 31.3. Samsung Biologics Co. Ltd.
  • 31.4. CMIC Holdings Co. Ltd.
  • 31.5. WuXi Biologics Inc.
  • 31.6. Fujifilm Diosynth Biotechnologies Inc.
  • 31.7. Evotec SE
  • 31.8. AGC Biologics Inc.
  • 31.9. CordenPharma International GmbH
  • 31.10. GenScript ProBio Co. Ltd.
  • 31.11. Syngene International Limited
  • 31.12. KBI Biopharma Inc.
  • 31.13. Rentschler Biopharma SE
  • 31.14. BioVectra Inc.
  • 31.15. Polpharma Biologics S.A.

32. Global Mammalian Cell Banking Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Mammalian Cell Banking Market

34. Recent Developments In The Mammalian Cell Banking Market

35. Mammalian Cell Banking Market High Potential Countries, Segments and Strategies

  • 35.1 Mammalian Cell Banking Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Mammalian Cell Banking Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Mammalian Cell Banking Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer